A Phase 2 Study to Evaluate the Dose and Pharmacodynamic Efficacy of Sialic Acid-Extended Release (SA-ER) Tablets in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy
Clinical trial NCT01517880 · COMPLETED
Trial details
- NCT number
- NCT01517880
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2013-11-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.